Neuronetics (STIM) Gross Profit Growth (1y) (2018 - 2026)

Neuronetics (STIM) Gross Profit Growth (1y) (2018 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (1y) (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 6.52%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 1.76%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 10.88%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 12.59%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 15.74%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 27.39%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn -1.74%
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 6.30%
10 Neuronetics 126.30 Mn 120.30 Mn 16.15 Mn 2.64%

Historic Data

Download Data
DateValue
Mar 31, 2026 2.64%
Dec 31, 2025 45.73%
Sep 30, 2025 22.19%
Jun 30, 2025 45.81%
Mar 31, 2025 20.25%
Dec 31, 2024 -5.57%
Sep 30, 2024 19.02%
Jun 30, 2024 -4.66%
Mar 31, 2024 14.85%
Dec 31, 2023 14.22%
Sep 30, 2023 -9.00%
Jun 30, 2023 3.94%
Mar 31, 2023 6.54%
Dec 31, 2022 20.24%
Sep 30, 2022 21.33%
Jun 30, 2022 7.31%
Mar 31, 2022 6.25%
Dec 31, 2021 -2.81%
Sep 30, 2021 8.82%
Jun 30, 2021 54.39%